Marksans Pharma’s stock saw a significant uptick, jumping over 3% ahead of its Q2 FY25 results.
The stock opened at ₹290.70, reaching a high of ₹299.20, and closing near its low of ₹290.65. With a 52-week high of ₹328.80 and a low of ₹130.00, the recent surge reflects growing investor confidence.
Market watchers are closely anticipating the company’s upcoming financial results, which could impact future stock performance.
As of 11:17 am, Marksans Pharma shares were trading 3.29% higher at Rs 298.10 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
